To detect changes in intranuclear Ikaros in immune cells following Pom therapy, cells labeled with T and NK cell markers were fixed and permeabilized using the BD Pharmingen Transcription Factor Buffer Set using the recommended protocol. A fluorochrome-conjugated monoclonal antibody against IKZF1 (R32-1149) was used to detect intranuclear levels of the protein.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.